Slaughter and May advised DeepMind on the creation of Isomorphic Labs

Slaughter and May advised DeepMind Technologies Limited (DeepMind) on the creation of Isomorphic Labs, a new Alphabet company. Isomorphic Labs is a commercial venture that will adopt an AI-first approach to drug discovery and biology.

Isomorphic Labs is owned by Alphabet, the ultimate parent of DeepMind, and will build on the research of DeepMind’s breakthrough protein-folding AI system AlphaFold2 (including through partnerships with pharmaceutical and biomedical companies). It has a mission to use AI to accelerate drug discovery and ultimately find cures for some of humanity’s most devastating diseases.